Study Information

About the study

The purpose of this study is to investigate how AB680 is metabolised when it is administered to healthy participants. It will also be investigated how quickly and to what extent AB680 is absorbed and eliminated from the body. This medication works to block the action of an enzyme that generates adenosine, a chemical which can lead to a decrease in the immune systems response towards cancer. With the help of our participants, this medication may eventually be used for the treatment of cancer.

Volunteers will be reimbursed up to $300 per day during the inpatient stay for their time and inconvenience.

What’s involved?

3 days & nights inpatient stay plus 3 follow-up appointments over the following 12 days.

How do I find out more?

If you are interested in participating or would like more information, please register below. If you have already registered with us but would like more information regarding this study, please call 1800 243 733 or email reply@nucleusnetwork.com.au and quote “Summer Study”.

 

  • 3
    Nights Inpatient Stay
  • 3
    Outpatient Visits

Minimum Eligibility Requirements:

  • Healthy Males and Females
  • Aged 18 – 55 years old
  • BMI 18 – 30 kg/m²
  • Social smokers OK (No more than 5 cigarettes per week in the last 3 months)
  • Not taking any prescription medication or over the counter medication
Top